Investors / United States / View Ventures
View Ventures
Venture capital · Dallas, TX, United States · North America
View Ventures is an investment firm focused on earlier stage medical and health technologies. Its founder and Managing Partner, Carter Meyer, previously led the management company for three life science investment funds of Scientific Health Development and serves on the boards of its portfolio companies.
Invests inHealthcare & Biotech
In its own wordsmedical deviceshealth techlife sciencesminimally invasiveophthalmologycardiology
Your fit with View Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsView Ventures lists 6 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (71%), Fintech (14%) and Space & Defense (14%). 80% of its companies are based in United States. It invests most often alongside 1809 Capital, BioStar Capital and MedVenture Partners.
Counts come from funding rounds that name View Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundView Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 0% |
| Series B | 0% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 73th | 50% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 92th | 71% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| 1809 Capital | 1 |
| BioStar Capital | 1 |
| MedVenture Partners | 1 |
| S3 Ventures | 1 |
| SUM Ventures | 1 |
| Santa Cruz Ventures | 1 |
| SeedFolio | 1 |
| ShangBay Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 71% | 15% |
| Fintech | 14% | 12% |
| Space & Defense | 14% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare View Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with View Ventures| Date | Company | Stage |
|---|---|---|
| 11 Aug 2026 | Series C+ | |
| 11 Feb 2026 | Seed |
Round details for View Ventures
Amounts, full round histories and every co-investor in View Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adminflow provides a SaaS platform for accounting firms and boards to manage tasks, customers, and documents | FintechSpace & Defense | Feb 2026Seed | Funding round | |
| Brius Technologies Inc produces and markets hidden braces for teeth straightening | Healthcare & Biotech | Portfolio page | ||
| Euphrates Vascular develops a nanoscale interventional device to diagnose and treat complex vascular occlusions | Healthcare & Biotech | Portfolio page | ||
| Rivermark Medical develops a device treatment for Benign Prostatic Hyperplasia (BPH) called FloStent | Healthcare & Biotech | Portfolio page | ||
| Spirair develops medical devices for ear, nose, and throat treatments. | Healthcare & Biotech | Portfolio page | ||
| Versa Vascular is developing a minimally invasive treatment option for patients with severe tricuspid regurgitation | Healthcare & Biotech | Aug 2026Series C+ | Page + round |
About this data
site last read 5 Nov 2026- Site
- view-ventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Feb 2026
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get View Ventures' profile as data
Pull View Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/view-ventures.com
# also
GET /v1/firms/view-ventures.com/portfolio
GET /v1/firms/view-ventures.com/coinvestors
GET /v1/firms/view-ventures.com/news